The Comparability of Bispectral Index and Neurosense During Anesthesia

NCT ID: NCT00910416

Last Updated: 2016-09-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

40 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-05-31

Study Completion Date

2010-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The assessment of anesthesia depth was based, until recently, on the evolution of hemodynamic parameters. Nowadays it can be evaluated by several monitoring methods, derived from electroencephalogram analysis, namely the Bispectral Index (Aspect Medical Systems, Newton, USA). A new modality is currently under development: the NeuroSENSE (Cleveland Medical Devices Inc., Cleveland, OH 44103, USA). The goal of this study is to compare both monitoring modalities during anesthesia.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anesthesia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

patients receiving iv anesthesia

propofol, remifentanil, atracurium

Intervention Type DRUG

propofol, remifentanil, atracurium dosages are adapted according to clinician's judgment

EEG monitoring

Intervention Type DEVICE

simultaneous monitoring with Bis and Neurosense

patients receiving balanced anesthesia

propofol, remifentanil, atracurium, sevoflurane

Intervention Type DRUG

dosages are adapted according to clinician's judgment

EEG monitoring

Intervention Type DEVICE

simultaneous monitoring with Bis and Neurosense

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

propofol, remifentanil, atracurium

propofol, remifentanil, atracurium dosages are adapted according to clinician's judgment

Intervention Type DRUG

propofol, remifentanil, atracurium, sevoflurane

dosages are adapted according to clinician's judgment

Intervention Type DRUG

EEG monitoring

simultaneous monitoring with Bis and Neurosense

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients requiring either intravenous anesthesia or balanced anesthesia (including sevoflurane)

Exclusion Criteria

* Pregnant women,
* Allergy to propofol, remifentanil, morphine, muscle relaxant, or to a component,
* Hypersensibility to sufentanil, remifentanil or to a derivate of fentanyl,
* History of neurological disorder or central brain lesion, of muscle disease,
* Patient carrying a pacemaker,
* Patients receiving a psychotropic treatment or a morphine agonist-antagonist,
* Alcoholic patients and patients taking opiates,
* Surgery with extracorporeal circulation,
* Surgical position incompatible with an adequate positioning of the probe.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hopital Foch

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Marc Fischler, MD

Role: STUDY_CHAIR

Hôpital Foch

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Dept of Anesthesia, Hôpital Foch

Suresnes, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Zikov T, Bibian S, Dumont GA, Huzmezan M, Ries CR. Quantifying cortical activity during general anesthesia using wavelet analysis. IEEE Trans Biomed Eng. 2006 Apr;53(4):617-32. doi: 10.1109/TBME.2006.870255.

Reference Type BACKGROUND
PMID: 16602568 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2008/22

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Recovery From General Anesthesia
NCT00165971 COMPLETED NA